The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells

Blood

Volumn 92, Issue 3, 1998, Pages 1011-1019

  Larocca, Luigi Maria ^a   Capello, Daniela ^b   Rinelli, Alessandro ^b   Nori, Simonetta ^b   Antinori, Andrea ^b   Gloghini, Annunziata ^b   Cingolani, Antonella ^b   Migliazza, Anna ^b   Saglio, Giuseppe ^b   Cammilleri Broet, Sophie ^b   Raphael, Martine ^b   Carbone, Antonino ^b   Gaidano, Gianluca ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; BRAIN LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GERMINAL CENTER; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLAST; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

B-LYMPHOCYTE SUBSETS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLONE CELLS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENES, MYC; GERMINAL CENTER; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0032147263     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Levine AM: AIDS-related malignancies: The emerging epidemic. J Natl Cancer Inst 85:1382, 1993
2. DeAngelis LM, Yahalom J: Primary central nervous system lymphoma, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer. Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven, 1997, p 2233
3. Goplen AK, Dunlop O, Hardy CR, Yellin FJ, Hartge P: The impact of primary central nervous system lymphoma in AIDS patients: A population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Human Retrovirol 14:351, 1997
4. Fine HA, Loeffler JS: Primary central nervous system lymphoma, in Canelios GP, Lister TA, Sklar JL (eds): The Lymphomas, Philadelphia, PA, Saunders, 1998, p 481
5. Beral V, Peterman T, Berkelman R, Jarfe H: AIDS-associated non-Hodgkin lymphoma. Lancet 337:805, 1991
6. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst 88:675, 1996
7. Miller DC, Hochberg FH, Harris NL: CNS lymphoma update. J Neurooncol 12:264, 1992
8. Jellinger KA, Paulus W: Primary central nervous system lymphomas: An update. J Cancer Res Clin Oncol 119:7, 1992
9. Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P, Epardeau B, Navratil E, Mokhtari K, Bourgeois C, Marelle L, Raphael M, Hauw J-J and the French Study Group for HIV-Associated Tumors: AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases. Hum Pathol 28:367, 1997
10. MacMahon EME, Glass JD, Hayward SD, Mann RB, Beker PS, Charache P, McArthur JC, Ambinder RF: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338:969, 1991
11. Geddes JF, Bhattacharjee MB, Savage K, Scaravilli F, McLaughlin JE: Primary cerebral lymphoma: A study of 47 cases probed for Epstein-Barr virus genome. J Clin Pathol 45:587, 1992
12. Morgello S: Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Am J Pathol 141:441, 1992
13. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken JHJM, Pallesen G: Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072, 1993
14. Itoyama T, Sadamori N, Tsutsumi K, Tokunaga Y, Soda H, Tomonaga M, Yamamori S, Masuda Y, Oshima K, Kikuchi M: Primary central nervous system lymphomas. Immunophenotypic, virologie, and cytogenetic findings of three patients without immune defects. Cancer 73:455, 1995
15. Antinori A, Ammassari A, De Luca A, Cingolani A, Murri R, Scoppettuolo G, Fortini M, Tartaglione T, Larocca LM, Zannoni G, Cattani P, Grille R, Roselli R, lacoangeli M, Scerrati M, Ortona L: Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48:687, 1997
16. Camilleri-Broet S, Davi F, Feuillard J, Bourgeois C, Seilhean D, Hauw J-J, Raphael M: High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 86:432, 1995
17. Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R: Cloning of BCL-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 53:2732, 1993
18. Ye BH, Lista F, Lo Coco F, Knowles DM, Chaganti RSK, Dalla-Favera R: Alterations of BCL-6, a novel zinc-finger gene, in diffuse large cell lymphoma. Science 262:747, 1993
19. Baron BW, Nucifora G, McNabe N, Espinosa R III, Le Beau MM, McKeithan TW: Identification of the gene associated with the recurrent chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27; qll) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262, 1993
20. Kerckaert J-P, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C: LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 trans locations in human lymphoma. Nat Genet 5:66, 1993
21. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS, Dalla-Favera R: BCL-6 protein is expressed in germinal-center B cells. Blood 86:45, 1995
22. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589, 1997
23. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161, 1997
24. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BY, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R: Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520, 1995
25. Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RSK, Dalla-Favera R: Rearrangements of the BCL-6 gene in diffuse large cell non-Hodgkin lymphoma. Blood 83:1757, 1994
26. Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A, Roncella S, Ferrarim M, Saglio G, Dalla-Favera R: Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 89:3755, 1997
27. Gaidano G, Pastore C, Capello D, Migliazza A, Gloghini A, Saglio G, Carbone A, Dalla-Favera R: Involvement of the bcl-6 gene in AIDS-related lymphomas. Ann Oncol 8:S105, 1997 (suppl 2)
28. Capello D, Carbone A, Pastore C, Gloghini A, Saglio G, Gaidano G: Point mutations of the BCL-6 gene in Burkitt's lymphoma. Br J Haematol 99:168, 1997
29. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 49:2112, 1982
30. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolfe-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri S, Piris MA, Ralfkiaer E, Wamke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
31. Carbone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U, Dalla-Favera R, Falini B: BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas. Am J Pathol 150:155, 1997
32. Carbone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, Antinori A, Tirelli U, Falini B, Dalla-Favera R: Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virusencoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 91:747, 1998
33. Flenghi L, Ye BH, Fizzotti M, Bigema B, Cattoretti G, Venturi S, Pacini R, Pileri S, Lo Coco F, Pescarmona E, Pelicci P-G, Dalla-Favera R, Falini B: A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol 147:405, 1995
34. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 11:1674, 1993
35. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
36. Gaidano G, Pastore C, Gloghini A, Cusini M, Nomdedeu J, Volpe G, Capello D, Vaccher E, Bordes R, Tirelli U, Saglio G, Carbone A: Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 10:941, 1996
37. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R: Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81:166, 1993
38. Volpe G, Vitolo U, Carbone A, Pastore C, Bertini M, Botto B, Audisio E, Freilone R, Novero D, Cappia S, De Giuli P, Mazza U, Resegotti L, Palestro G, Saglio G, Gaidano G: Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosom Cancer 16:21, 1996
39. Lennert K, Feller A: Histopathology of non-Hodgkin's Lymphomas (ed 2). New York, NY, Springer-Verlag, 1992
40. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027, 1993
41. Wilson TM, Ewel A, Duguid JR, Eble JN, Lescoe MK, Fishel R, Kelley MR: Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res 55:5146, 1995
42. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, Wyllie AH, Paltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW, Vogelstein B: Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 56:235, 1996
43. Marra G, Chang CL, Laghi LA, Chauban DP, Young D, Boland R: Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells. Oncogene 13:2189, 1996
44. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R, Hailing KC: Altered expression of hMSH2 and hMLHl in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56:4836, 1996
45. Migliazza A, Ye BH, Fracchiolla N, Neri A, Baldini L, Chaganti RSK, Dalla-Favera R: Mutation of the 5′ non-coding region of BCL-6 are common in B cell malignancies and can deregulate BCL-6 expression. Blood 90:177a, 1997 (suppl 1)
46. Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, Dalla-Favera R: Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood 84:397, 1994
47. Cattoretti G, Zhang J, Cleary AM, Lederman S, Gaidano G, Carbone A, Chaganti RSK, Dalla-Favera R: Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP-1) and its block in lymphottia carrying BCL-6 rearrangements. Blood 90:175a, 1997 (abstr, suppl 1)